Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01036217 · ClinicalTrials.gov registry record
Screening Protocol for the Evaluation of Research Participants
A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- 55,000
- Enrollment target
NCT01036217: Completed study, sponsored by National Institute on Drug Abuse (NIDA).
NCT01036217 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 55,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01036217 has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- 55,000 participants
- Enrollment target
Study Summary
Background: \- The National Institute on Drug Abuse (NIDA) uses a standardized set of procedures to develop a pool of potential participants for research studies. Because some of the data collected during screening are used later for research, the screening itself is considered a study. An applicant to any NIDA study is considered a participant in NIDA screening. Objectives: \- To identify, recruit, and screen participants for NIDA research protocols. Eligibility: \- Individuals 18 years of age and older who are able to provide informed consent. Design: * Individuals who are eligible for screening will undergo two interviews: a telephone interview and an in-person interview. The phone interview will determine eligibility for the in-person interview. * The in-person interview may require up to five visits to NIDA. The in-person visit will involve any or all of the following procedures: (1) full physical examination and medical history; (2) psychiatric interview; (3) psychological testing; (4) electrocardiogram; (5) samples of blood, urine, and hair; and (6) other minimally invasive procedures as directed by the research staff. * During screening, a photograph will be taken for confirmation of identity during subsequent visits for other studies. * No clinical care will be provided as part of screening.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55,000 participants |
| Start Date | 2006-05-17 |
| Est. Completion | 2010-06-17 |
What the finished NCT01036217 record still lists
NCT01036217 is an observational study that tracks outcomes without assigning an intervention. Its 55,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01036217 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01036217 about?
NCT01036217 is a clinical study titled "Screening Protocol for the Evaluation of Research Participants". Background: \- The National Institute on Drug Abuse (NIDA) uses a standardized set of procedures to develop a pool of potential participants for research studies. Because some of the data collected during screening are used later for research, the screening itself is considered a study. An applican...
What is the current status of trial NCT01036217?
This trial is currently completed. The enrollment target is 55,000 participants. The study started on 2006-05-17. Estimated completion is 2010-06-17.
Who is sponsoring clinical trial NCT01036217?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07224243 · 54,000 participants · NA
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
- NCT05975671 · 52,500 participants · NA
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
- NCT06355934 · 52,121 participants
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
- NCT00785525 · 60,000 participants · Phase 3
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI